Simultaneous evaluation of myocardial function, viability, and microvascular dysfunction by a new magnetic resonance technique  by Raff, Gilbert L. et al.
JACC March 19,2003 ABSTRACTS - Noninvasive Imaging 45 1 A 
1167-39 The Transmural Extent of Necrosis Modulates the 
Contractile Response of Metabolically Viable 
Myocardium to Dobutamine 
Bernhard L. Gerber, Agnes Pasquet. Vgronique Roelants, David Vancraeynesf Anne 
Marie D’Hondt, Jean-Louis J. Vanoverschelde. Universit.4 Catholique de Louvain, 
Brussels, Belgium 
Background: Both positron emission tomography (PET) and low-dose dobutamine 
echocardiography (LDE) have been proposed to assess the presence of viable myocar- 
dium. Although both of these modalities share the same final purpose, i.e. to predict 
which segment is likely to resume contractile function following revascularization, they 
frequently disagree on the presence of segmental viability. In particular, many segments 
with preserved metabolic viability lack evidence of contractile reserve during LDE. The 
am of this study was lo determine whether small subendocardial infarcts might contrib- 
ute to the lack of inotropic reserve in metabolically viable myocardium. Methods: Thir- 
teen patients (10 M. 60+11 years) with CAD and altered cardiac function (EF X+15%) 
underwent FDG-PET. LDE and Gd-enhanced MRI for the assessment of mvocardial via- 
bility. Baseline contractile function, inotropic reserve (LDE) and the transmural extent of 
necrosis Iouantitative late-enhancement MRI) were cornoared amona PET viable (>60% 
I  
remote FDG uptake) segments and non-viable as well as in LDE responding and non- 
responding segments. Results: At baseline, 1271208 segments were dysfunctional. 
Sixty-four of these segments were considered PET viable, whereas 63 were PET non- 
viable. Among the 63 PET non-viable segments. 53 (84%) did not improve during LDE. 
Conversely, among the 64 PET viable segments only 24 (38%) improved contraction 
with dobutamine. Gd-enhanced MRI demonstrated that PET viable segments had less 
transmural necrosis than PET non-viable segments (20*21 vs. 61*26% pc.001). The 
extent of necrosis was also lower in dobutamine responsive PET viable segments than in 
dobutamine non responsive PET viable segments (13+12 vs. 31+22%, p-z.001). Conclu- 
sions: The transmural extent of necrosis is larger in metabolically viable segments that 
fail lo respond to dobutamine than in those exhibiting contractile reserve. The presence 
of more extensive subendocardial infarction probably contributes lo the lower sensitivity 
of LDE vs. PET for the detection of myocardial wability. 
1167-40 Myocardial Hyperenhancement by Magnetic Resonance 
Imaging in Genotyped Hypertrophic Cardiomyopathy 
Patients Identifies Early Disease and Correlates With 
Clinical Risk 
James C. Moon Jens Mogensen, Gillian C. Smith. Andrew G. Elkmgton, San]ay Prasad, 
Perry M. Elliott, Dudley J. Pennell, William J. McKenna, Royal Brompton Hospital, 
London, United Kingdom, St. George’s Hospital, London, United Kingdom 
Introduction: Some patients with Hypertrophlc Cardiomyopathy (HCM) have abnormal 
areas of myocardial hyperenhancement after gadolinium-DTPA by Cardiovascular Mag- 
netic Resonance (CMR). This is believed to represent myocardial fibrosis or disarray, but 
the precise histology and relationship to genotype and disease stage is unknown. We 
examined a cohort of genotyped subjects all carrying the same sarcomeric protein muta- 
tion (Troponin I) to assess the relationship between hyperenhancement and disease 
stage and to assess whether CMR could detect early disease. 
Methods: Thirty patients from 13 families underwent tine and contrast enhanced CMR. 
15 patients fulfilled WHO criteria for HCM with abnormal wall thickness on echo (G+/ 
LVH+) and 15 were gene positive with a normal echo (G+/LVH-). 
Results:All (100%) G+/LVH+ pabents and 4 (27%) G+/LVH- patients had abnormal tine 
CMR imaging with abnormal regional hypertrophy. Abnormal hyperenhancement was 
present in 12 (86%) G+/LVH+ patients and 3 (20%) G+/LVH-. Where present. the mean 
extent of hyperenhancement in the G+/LVH+ patients was 15% (range 3-48%) and less 
in G+/LVH-patients (3.6%). Overall, the extent of hyperenhancement was related to high 
clinical nsk of sudden death 62 standard risk factors for sudden death), (mean 15% high 
risk vs 4%, p=O.O3), total LV mass (rz0.56, p<O.OOl) and inversely to ejection fraction 
(r=0.58.p<0.001). Increased hyperenhancement was not associated with age over the 
whole group, but was when comparisons were made within families. Segmental analysis 
showed that as segmental wall thlckness increased, hyperenhancement was more prev- 
alent (p<O.OOOl for trend) and more extensive (r=0.99). 
Conclusion: Hyperenhancement occurs in almost all G+/LVH+ patients, and a sigmfi- 
cant number of G+/LVH- patients. The intra-pedigree relationship of hyperenhancement 
with subject age is evidence that hyperenhancement increases over time as the pheno- 
type evolves. Hyperenhancement may have a role both in the diagnosis of early disease 
and as a new marker for cknical risk. 
1167-41 Determination of Infarct Size by Contrast-Enhanced 
MRI: Comparison Between Quantitative Planimetry and 
a Semiquantitative Visual Score Method 
Clerio F. Azevedq Marc& Hadlich, Joeo L. Petri& Luis A. Mendonpa. Jorge Mall, 
Carlos E. RochWe, Rede D’Or 8 Labs, Rio de Janeiro, Brazil, Heart Institute (lncor), 
University of SBo Paula Medical School, SBo Paula. Brazil 
Background: Delayed-enhanced MRI can measure infarct srze precisely, which has 
important clinical and prognostic significance. We examined whether a faster semiquanti- 
tative visual score method is valid to determine infarct size when compared to the quanti- 
tative and time-consuming planimetric method. 
Methods: Sixty-two patients with previous myocardial infarction underwent contrast- 
enhanced MRI on a 1.5T whole-body magnet (Intera NT, Philips). Eight short-axis slices 
covering the whole left ventricle (LV) were acquired and analyzed in two ways: manual 
drawing of the hyperenhanced regions and LV endocardial and epicardlal borders to 
determine infarct size as a percent of LV mass (planimetry, PL); visual evaluation by 
score (VS) of all 8 slices, divided in 48 segments (2 basal slices with 8 segments, 4 mid- 
dle slices with 6 segments and 2 apical slices with 4 segments. therefore weighting for 
the segment mass), by Iwo independent observers that were blind to the planimetry 
results. They graded the transmural extent of hyperenhancement on a four-point scale in 
which a score of 0 indicated no hyperenhancemenl a score of 1 hyperenhancement of 1 
to 25% of tissue within a segment, a score of 2 hyperenhancement of 26 to 75%, and a 
score of 3 more than 75%. The final score of each patient was then divided by the total 
possible score, providing the infarct size as percent of LV mass. 
Results: Mean infarct size was similar by PL versus VS (19.8*1.4% vs. 18.6+1.3%. P 
NS). Correlation’coefficient for PL vs. VS was good for both observers (r=O.90 and 0.82, 
P<O.Ol). Bland -Altman analyses revealed a mean difference of -1.2%, with a 95% confi- 
dence Internal for the differences between PL and VS ranging from -11 .O to 8.6% More- 
over, good correlation was observed between VS and LV ejection fraction (r=0.75, 
P<O.Ol). 
Conclusion: The visual semiquantitative evaluation of the delayed-enhanced images by 
the score method showed good accuracy and reproducibility lo determine the percent of 
infarcted LV mass when compared to the quantitative planimetric method. Therefore, inf- 
arct sizing by the score method can be used in routine cardiac MRI exams, adding objec- 
tive data to the report and significantly decreasing post-processing time. 
1167-42 Assessment of Myocardial Viability in Patients With Left 
Ventricular Dysfunction Using Contrast-Enhanced 
Magnetic Resonance Imaging : Comparison to 201- 
Thallium Single Photon Emission Computed 
Tomography 
Matthias Reaenfus, Christian Schlundt, Johannes von Erffa, Roberi KrBhner, Dieter 
Ropers, Stephan Achenbach. Michaela Schmidt. Niels Oesingmann, Kristin 
Schmiedehausen, Gijnther Platsch. Torsten Kuwerl. Werner G. Daniel, FAU Erlangen- 
Niirnberg, Erlangen, Germany, Siemens Medical Solutions, Eriangen, Germany 
Objective: We compared contrast-enhanced (ce) magnetic resonance imaging (MRI) and 
201-TI SPECT concerning detection of myocardial viability in patients with left ventricular 
dysfunction. 
Methods: 53 patients (pts) with left ventricular dysfunction (EF 39+15%) who had suf- 
fered myocardial infarction (Ml) (28 chronic MI. 27 within 7 days of acute Ml) were exam- 
ined. Ce images were acquired 10 min after intravenous injection of 0.1 mmolfkg Gd- 
DTPA. SPECT was performed according to standard protocols. A 14.segment model of 
corresponding basal, midventricular and apical slices was analysed independently for 
MRI and SPECT. Segmental hyperenhancement (HE) for MRI and defect size for 
SPECT was visually graded. Segments were categorized as viable or nonviable accord- 
ing to SPECT. Moreover, segmental extent of infarction (SEI) was quantified for MRI. 
Results: Viable (78%, 579/742) segments by SPECT showed significantly less SEI corn- 
pared to nonviable (22%, 163/742) segments (12.3*19.7% vs. 61.1*27.5%, p<O.OOOl). 
Summed SPECT score and summed MRI score showed close agreement for pts with 
chronic MI (r=0.8. p<O.OOOl) and acute MI (r=0.9, p<O.OOOl). However, SPECT failed lo 
detect 70 of 352 (20%) seamen& showina HE bv MRI. and. on a oatient basis. missed 7 ,_ _ . 
of 53 (11%) of pts with small MI, which had all been detected by MRI. Moreover, of 183 
seaments assessed nonviable bv SPECT onlv 83 151%) showed transmural HE. 
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Conclusion: Ce MRI and SPECT show a close overall correlation for determination of 
myocardial viability. Potential advantage of MRI is the superior spatial resolution which 
allows for determination of both the transmural extant and delineation of small myocar- 
dial necrosis. 
1167-43 Simultaneous Evaluation of Myocardial Function, 
Viability, and Microvascular Dysfunction by a New 
Magnetic Resonance Technique 
Gilbert L. R&l. Beth A. Barlholomew, Ralph Gentry, Anil N. Shetty, Koslakis G. Bis, 
James A. Goldstein, William W. O’Neill. William Beaumont Hospital, Royal Oak, Ml 
Background In patients with acute coronary syndromes, the ability to rapidly delineate 
hibernating myocardium and assess microvascular dysfunction (MD) has therapeutic 
implications. At present such analyses are performed by standard cardiac magnetic res- 
onance techniques (ST) combining delayed enhancement and tine function study. We 
developed a new method, contrast-enhanced tine magnetic resonance (CEC), that 
simultaneously does both. This study compared CEC to ST for diagnosis and total exam 
time. 
Methods 18 patients were studied to date: 7 with acute infarction within 24 hours and at 
1 week, and 11 over 3 months post-infarction. After a 0.20 mmolikg gadolinium first-pass 
study, patients were imaged by an ECG-g&d, segmented k-space, inversion recovery, 
multi-slice true-FISP sequence. 9 short axis and horizontal and vertical long-axis slices 
were obtained. This completed the CEC exam. ST exam followed, using a standard 
inversion-recovery turbo-FLASH sequence. Areas of delayed hyperenhancement (DH) 
and hypoenhancement (MD) were planimetered for size and transmurality score. 
Results DH area by the two techniques was highly correlated (0.92, P<O.OOOl), as was 
MD (0.60, P<O.OOOl) and transmurality score (0.60, <O.OWl). CEC reduced exam time 
by 38% (15 +/- 6 minutes vs 24 +/- 5 minutes). 
Conclusions These findings demonstrate that this novel method contrast-enhanced 
tine magnetic resonance, can rapidly assess myocardial viability and microvascular dys- 
function. This more rapid technique may be advantageous in the evaluation of patients 
with acute coronary syndromes. 
